Stay updated on OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check4 days agoChange DetectedThe OPERA-01 study record is available with its clinical-trial details, including participant criteria, treatment arms, measured outcomes, and 233 study locations. It is listed as active but no longer recruiting.SummaryDifference100%

- Check11 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA general NIH announcement about terminology during a website transition was added to the error page, and the site revision label changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, blocking access to the study record and related content.SummaryDifference18%

- Check60 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0, indicating a newer version of the page content.SummaryDifference0.0%

Stay in the know with updates to OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.